A PHASE 2B LONG-TERM, RANDOMIZED, OPEN-LABEL, SAFETY AND TOLERABILITY TRIAL COMPARING [S,S]-REBOXETINE (PNU-165442G) WITH ROUTINE CARE IN PATIENTS WITH CHRONIC PAINFUL DIABETIC PERIPHERAL NEUROPATHY (DPN).

Registry ID

EUCTR2006-001307-11

Source registry

EUCTR

Status

Prematurely Ended

Phase

PHASE2

Sponsor

Pfizer Ltd

Start date

2006-08-03

Completion date

2008-08-04

Last update

2026-08-16

Conditions

• Diabetic Peripheral Neuropathy

Summary

To assess the long-term safety and tolerability of [S,S]-RBX in patients with DPN.

Locations

• , , Estonia
• , , UK
• , , Sweden
• , , Germany
• , , Finland

Related clinical trials

• Functional and Neuroprotective Effects of Restoring Lower Limb Sensation After Diabetic Peripheral Neuropathy
• Spinal Cord Stimulation and Small Fiber Peripheral Neuropathy
• Effect of Melatonin in Patients With Diabetic Peripheral Neuropathy
• Walking Function in Diabetic Peripheral Neuropathy
• Shortwave Intervention for Diabetic Peripheral Neuropathy.
• Ultrasound-Guided Nerve Hydrodissection for Diabetic Lower Limb Entrapment Neuropathy

View on source registry